Literature DB >> 11885030

A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome.

Sabine M Klauck1, Susan Lindsay, Kim S Beyer, Miranda Splitt, John Burn, Annemarie Poustka.   

Abstract

We report here the genetic cause of the X-linked syndrome of psychosis, pyramidal signs, and macro-orchidism (PPM-X) in a three-generation family manifesting the disorder as a mutation in the methyl-CpG binding-protein 2 (MECP2) gene in Xq28. The A140V mutation was found in all affected males and all carrier females in the family. To date, descriptions have been published of two patients with independent familial mental retardation (MR) and two patients with sporadic MR who harbor this specific mutation in the MECP2 gene. This strongly suggests that A140V is a hot spot of mutation resulting in moderate to severe MR in males. A simple and reliable PCR approach has been developed for detection of the hot spot A140V mutation to prescreen any other unexplained cases of MR before further extensive mutation analyses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11885030      PMCID: PMC379098          DOI: 10.1086/339553

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients.

Authors:  V Bourdon; C Philippe; O Labrune; D Amsallem; C Arnould; P Jonveaux
Journal:  Hum Genet       Date:  2001-01       Impact factor: 4.132

2.  Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males.

Authors:  J Clayton-Smith; P Watson; S Ramsden; G C Black
Journal:  Lancet       Date:  2000-09-02       Impact factor: 79.321

3.  MECP2 is highly mutated in X-linked mental retardation.

Authors:  P Couvert; T Bienvenu; C Aquaviva; K Poirier; C Moraine; C Gendrot; A Verloes; C Andrès; A C Le Fevre; I Souville; J Steffann; V des Portes; H H Ropers; H G Yntema; J P Fryns; S Briault; J Chelly; B Cherif
Journal:  Hum Mol Genet       Date:  2001-04-15       Impact factor: 6.150

4.  Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes.

Authors:  R E Amir; I B Van den Veyver; R Schultz; D M Malicki; C Q Tran; E J Dahle; A Philippi; L Timar; A K Percy; K J Motil; O Lichtarge; E O Smith; D G Glaze; H Y Zoghbi
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

5.  Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA.

Authors:  I Ohki; N Shimotake; N Fujita; J Jee; T Ikegami; M Nakao; M Shirakawa
Journal:  Cell       Date:  2001-05-18       Impact factor: 41.582

Review 6.  Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.

Authors:  R E Amir; H Y Zoghbi
Journal:  Am J Med Genet       Date:  2000

7.  MECP2 mutation in male patients with non-specific X-linked mental retardation.

Authors:  A Orrico; C Lam; L Galli; M T Dotti; G Hayek; S F Tong; P M Poon; M Zappella; A Federico; V Sorrentino
Journal:  FEBS Lett       Date:  2000-09-22       Impact factor: 4.124

8.  Two affected boys in a Rett syndrome family: clinical and molecular findings.

Authors:  L Villard; A Kpebe; C Cardoso; P J Chelly; P M Tardieu; M Fontes
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

9.  Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location.

Authors:  J P Cheadle; H Gill; N Fleming; J Maynard; A Kerr; H Leonard; M Krawczak; D N Cooper; S Lynch; N Thomas; H Hughes; M Hulten; D Ravine; J R Sampson; A Clarke
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

10.  Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms.

Authors:  I M Buyse; P Fang; K T Hoon; R E Amir; H Y Zoghbi; B B Roa
Journal:  Am J Hum Genet       Date:  2000-10-30       Impact factor: 11.043

View more
  35 in total

Review 1.  Rett syndrome and MeCP2: linking epigenetics and neuronal function.

Authors:  Mona D Shahbazian; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2002-11-19       Impact factor: 11.025

Review 2.  X linked mental retardation: a clinical guide.

Authors:  F L Raymond
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

Review 3.  Rett syndrome: clinical review and genetic update.

Authors:  L S Weaving; C J Ellaway; J Gécz; J Christodoulou
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

4.  The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2.

Authors:  Jeffrey L Neul; Timothy A Benke; Eric D Marsh; Steven A Skinner; Jonathan Merritt; David N Lieberman; Shannon Standridge; Timothy Feyma; Peter Heydemann; Sarika Peters; Robin Ryther; Mary Jones; Bernhard Suter; Walter E Kaufmann; Daniel G Glaze; Alan K Percy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-12-07       Impact factor: 3.568

5.  Sex-specific rates of transmission of psychosis in the New England high-risk family study.

Authors:  Jill M Goldstein; Sara Cherkerzian; Larry J Seidman; Tracey L Petryshen; Garrett Fitzmaurice; Ming T Tsuang; Stephen L Buka
Journal:  Schizophr Res       Date:  2011-02-18       Impact factor: 4.939

Review 6.  Experimental models of Rett syndrome based on Mecp2 dysfunction.

Authors:  Gaston Calfa; Alan K Percy; Lucas Pozzo-Miller
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

7.  A boy with developmental regression.

Authors:  Kathryn MacLellan; Kellie Davies; Jennifer Fisher; Jean-Francois Lemay
Journal:  Paediatr Child Health       Date:  2018-05-18       Impact factor: 2.253

Review 8.  Chromosome abnormalities, mental retardation and the search for genes in bipolar disorder and schizophrenia.

Authors:  D H R Blackwood; T Thiagarajah; P Malloy; B S Pickard; W J Muir
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

9.  A novel hypomorphic MECP2 point mutation is associated with a neuropsychiatric phenotype.

Authors:  Abidemi A Adegbola; Michael L Gonzales; Andrew Chess; Janine M LaSalle; Gerald F Cox
Journal:  Hum Genet       Date:  2008-11-07       Impact factor: 4.132

10.  Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.

Authors:  Garilyn M Jentarra; Shannon L Olfers; Stephen G Rice; Nishit Srivastava; Gregg E Homanics; Mary Blue; Sakkubai Naidu; Vinodh Narayanan
Journal:  BMC Neurosci       Date:  2010-02-17       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.